Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Energy cost of ambulation in trans-tibial amputees using a dynamic-response foot with hydraulic versus rigid 'ankle': insights from body centre of mass dynamics.

Askew GN, McFarlane LA, Minetti AE, Buckley JG.

J Neuroeng Rehabil. 2019 Mar 14;16(1):39. doi: 10.1186/s12984-019-0508-x.

2.

Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine.

Cheeseman HM, Day S, McFarlane LR, Fleck S, Miller A, Cole T, Sousa-Santos N, Cope A, Cizmeci D, Tolazzi M, Hwekwete E, Hannaman D, Kratochvil S, McKay PF, Chung AW, Kent SJ, Cook A, Scarlatti G, Abraham S, Combadiere B, McCormack S, Lewis DJ, Shattock RJ.

Hum Gene Ther. 2018 Sep;29(9):1011-1028. doi: 10.1089/hum.2018.075.

3.

Ventral-Dorsal Functional Contribution of the Posterior Cingulate Cortex in Human Spatial Orientation: A Meta-Analysis.

Burles F, Umiltá A, McFarlane LH, Potocki K, Iaria G.

Front Hum Neurosci. 2018 May 8;12:190. doi: 10.3389/fnhum.2018.00190. eCollection 2018.

4.

Measuring and improving the quality of NHS care for children and young people.

Hargreaves DS, Lemer C, Ewing C, Cornish J, Baker T, Toma K, Saxena S, McCulloch B, McFarlane L, Welch J, Sparrow E, Kossarova L, Lumsden DE, Cheung CRLH.

Arch Dis Child. 2018 May 2. pii: archdischild-2017-314564. doi: 10.1136/archdischild-2017-314564. [Epub ahead of print] No abstract available.

5.

Launching first-year health sciences students into collaborative practice: Highlighting institutional enablers and barriers to success.

King S, Hall M, McFarlane LA, Paslawski T, Sommerfeldt S, Hatch T, Schmitz C, Bates H, Taylor E, Norton B.

J Interprof Care. 2017 May;31(3):386-393. doi: 10.1080/13561820.2016.1256870. Epub 2017 Jan 31.

PMID:
28140716
6.

Intra-specific variation in wing morphology and its impact on take-off performance in blue tits (Cyanistes caeruleus) during escape flights.

McFarlane L, Altringham JD, Askew GN.

J Exp Biol. 2016 May 1;219(Pt 9):1369-77. doi: 10.1242/jeb.126888. Epub 2016 Mar 18.

7.

West nile virus transmission in winter: the 2013 great salt lake bald eagle and eared grebes mortality event.

Ip HS, Van Wettere AJ, McFarlane L, Shearn-Bochsler V, Dickson SL, Baker J, Hatch G, Cavender K, Long R, Bodenstein B.

PLoS Curr. 2014 Apr 18;6. pii: ecurrents.outbreaks.b0f031fc8db2a827d9da0f30f0766871. doi: 10.1371/currents.outbreaks.b0f031fc8db2a827d9da0f30f0766871.

8.

Fostering interprofessional learning in a rehabilitation setting: development of an interprofessional clinical learning unit.

Vanderzalm J, Hall MD, McFarlane LA, Rutherford L, Patterson SK.

Rehabil Nurs. 2013 Jul-Aug;38(4):178-85. doi: 10.1002/rnj.78. Epub 2013 May 17. Erratum in: Rehabil Nurs. 2014 Mar-Apr;39(2):110.

PMID:
23686422
9.

Novel PCR assay for determining the genetic sex of mice.

McFarlane L, Truong V, Palmer JS, Wilhelm D.

Sex Dev. 2013;7(4):207-11. doi: 10.1159/000348677. Epub 2013 Apr 4.

10.

The Plasmodium berghei Ca(2+)/H(+) exchanger, PbCAX, is essential for tolerance to environmental Ca(2+) during sexual development.

Guttery DS, Pittman JK, Frénal K, Poulin B, McFarlane LR, Slavic K, Wheatley SP, Soldati-Favre D, Krishna S, Tewari R, Staines HM.

PLoS Pathog. 2013 Feb;9(2):e1003191. doi: 10.1371/journal.ppat.1003191. Epub 2013 Feb 28.

11.

Prospective follow-up of novel markers of bone turnover in persistent asthmatics exposed to low and high doses of inhaled ciclesonide over 12 months.

Anderson WJ, McFarlane LC, Lipworth BJ.

J Clin Endocrinol Metab. 2012 Jun;97(6):1929-36. doi: 10.1210/jc.2011-3410. Epub 2012 Mar 21.

PMID:
22438232
12.

Expansion of the Ago gene family in the teleost clade.

McFarlane L, Svingen T, Braasch I, Koopman P, Schartl M, Wilhelm D.

Dev Genes Evol. 2011 Jun;221(2):95-104. doi: 10.1007/s00427-011-0363-7. Epub 2011 May 11.

PMID:
21556854
13.

Homogenization of large-scale movement models in ecology.

Garlick MJ, Powell JA, Hooten MB, McFarlane LR.

Bull Math Biol. 2011 Sep;73(9):2088-108. doi: 10.1007/s11538-010-9612-6. Epub 2011 Jan 1.

PMID:
21194012
14.

A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination.

Nair A, Clearie K, Menzies D, Meldrum K, McFarlane L, Lipworth BJ.

Pulm Pharmacol Ther. 2009 Aug;22(4):305-10.

PMID:
19489129
15.

In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.

Nair A, Menzies D, Hopkinson P, McFarlane L, Lipworth BJ.

Br J Clin Pharmacol. 2009 Feb;67(2):191-8. doi: 10.1111/j.1365-2125.2008.03350.x. Epub 2009 Feb 9.

16.

Non-coding RNAs in mammalian sexual development.

McFarlane L, Wilhelm D.

Sex Dev. 2009;3(6):302-16. doi: 10.1159/000284688. Epub 2010 Feb 23. Review.

PMID:
20197714
17.

Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler.

Nair A, Menzies D, Barnes M, Burns P, McFarlane L, Lipworth BJ.

Br J Clin Pharmacol. 2008 Jul;66(1):20-6. doi: 10.1111/j.1365-2125.2008.03153.x. Epub 2008 Mar 13.

18.

Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate.

Tayab ZR, Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ, Hochhaus G.

Br J Clin Pharmacol. 2007 Nov;64(5):698-705. Epub 2007 May 17.

19.

Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma.

Menzies D, Nair A, Hopkinson P, McFarlane L, Lipworth BJ.

Allergy. 2007 Jun;62(6):661-7.

PMID:
17508971
20.

Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places.

Menzies D, Nair A, Williamson PA, Schembri S, Al-Khairalla MZ, Barnes M, Fardon TC, McFarlane L, Magee GJ, Lipworth BJ.

JAMA. 2006 Oct 11;296(14):1742-8.

PMID:
17032987
21.

Supreme Court slaps for-sale sign on medicare.

McFarlane L.

CMAJ. 2005 Aug 2;173(3):269-70. Epub 2005 Jun 20. No abstract available.

22.

Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.

Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.

Chest. 2005 Mar;127(3):851-60.

PMID:
15764767
23.

Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.

Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):253-8.

PMID:
15478385
24.

Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.

Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ.

Am J Respir Crit Care Med. 2004 Nov 1;170(9):960-6. Epub 2004 Jun 7.

PMID:
15184207
25.

Is a perfect storm brewing on the health care front?

McFarlane L.

CMAJ. 2004 May 25;170(11):1661-2. No abstract available.

26.

Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.

Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.

Allergy. 2003 Jul;58(7):602-7.

PMID:
12823118
27.

Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis.

Lee DK, Robb FM, Sims EJ, Currie GP, McFarlane LC, Lipworth BJ.

Br J Clin Pharmacol. 2003 Mar;55(3):310-3.

28.

Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate.

Fowler SJ, Orr LC, Sims EJ, Wilson AM, Currie GP, McFarlane L, Lipworth BJ.

Chest. 2002 Aug;122(2):618-23.

PMID:
12171841
29.

Determinants of absconding by patients on acute psychiatric wards.

Bowers L, Jarrett M, Clark N, Kiyimba F, McFarlane L.

J Adv Nurs. 2000 Sep;32(3):644-9.

PMID:
11012807
31.

Absconding: nurses views and reactions.

Clark N, Kiyimba F, Bowers L, Jarrett M, McFarlane L.

J Psychiatr Ment Health Nurs. 1999 Jun;6(3):219-24.

PMID:
10633675
32.

Absconding: outcome and risk.

Bowers L, Jarrett M, Clark N, Kiyimba F, McFarlane L.

J Psychiatr Ment Health Nurs. 1999 Jun;6(3):213-8.

PMID:
10633674
33.

Absconding: how and when patients leave the ward.

Bowers L, Jarrett M, Clark N, Kiyimba F, McFarlane L.

J Psychiatr Ment Health Nurs. 1999 Jun;6(3):207-11.

PMID:
10633673
34.

Absconding: why patients leave.

Bowers L, Jarrett M, Clark N, Kiyimba F, McFarlane L.

J Psychiatr Ment Health Nurs. 1999 Jun;6(3):199-205.

PMID:
10633672
35.

Comparative trough effects of formoterol and salmeterol on lymphocyte beta2-adrenoceptor--regulation and bronchodilatation.

Aziz I, McFarlane LC, Lipworth BJ.

Eur J Clin Pharmacol. 1999 Aug;55(6):431-6.

PMID:
10492055
36.

Is routine synovial fluid analysis necessary? Lessons and recommendations from an audit.

Pal B, Nash J, Oppenheim B, Dean N, McFarlane L, Maxwell S.

Rheumatol Int. 1999;18(5-6):181-2.

PMID:
10399793
37.

Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.

Wilson AM, Sims EJ, McFarlane LC, Lipworth BJ.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):598-604.

PMID:
9802367
38.

Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics.

Wilson AM, McFarlane LC, Lipworth BJ.

Chest. 1998 Oct;114(4):1022-7.

PMID:
9792571
39.

Outside. Mad to be gay. Interview by Catherine Jackson.

McFarlane L.

Ment Health Care. 1998 Mar;1(7):223. No abstract available.

PMID:
9791421
40.
41.
42.

Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.

Aziz I, Hall IP, McFarlane LC, Lipworth BJ.

J Allergy Clin Immunol. 1998 Mar;101(3):337-41.

PMID:
9525449
43.

Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.

Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.

Eur J Clin Pharmacol. 1998 Jan;53(5):317-20.

PMID:
9516029
44.
45.
46.
48.

Routine synovial fluid culture: is it necessary? Lessons from an audit.

Pal B, Nash EJ, Oppenheim B, Maxwell S, McFarlane L.

Br J Rheumatol. 1997 Oct;36(10):1116-7.

PMID:
9374931
49.

Supplemental Content

Loading ...
Support Center